ECCO 2021 Highlights Podcast Presented ByDr Rachel Giles, Medicom ConferenceECCO 2021 10 August, 2021 08:17
Similar efficacy of ustekinumab and adalimumab for moderate-to-severe CD Presented ByDr Peter Irving, Guy’s and St. Thomas’ Hospital, UK TrialSEAVUE ConferenceECCO 2021 2 July, 2021 23:45
Ustekinumab safe and effective in elderly CD patients Presented ByDr Diego Casas Deza, Hospital Universitario Miguel Servet TrialENEIDA registry ConferenceECCO 2021 2 July, 2021 22:50
Early clinical remission and response following risankizumab therapy in CD Presented ByDr Stefan Schreiber, University Hospital Schleswig-Holstein, Germany TrialADVANCE, MOTIVATE ConferenceECCO 2021 2 July, 2021 21:54
Risk of hospitalisation and surgery linked to IBD biological Presented ByDr Camilla Bjørn Jensen, Frederiksberg Hospital ConferenceECCO 2021 2 July, 2021 20:20
Obesity increases the risk of immunogenicity to adalimumab in IBD Presented ByDr Remi Mahmoud, University Medical Centre Utrecht, the Netherlands ConferenceECCO 2021 2 July, 2021 14:24
Upadacitinib meets primary endpoint for moderate-to-severe UC Presented ByDr Séverine Vermeire, University hospital Leuven, Belgium TrialPhase 3, U-ACCOMPLISH ConferenceECCO 2021 2 July, 2021 23:34
Promising safety and pharmacokinetic data on BT051 for UC Presented ByDr Chris Stevens, Bacainn Therapeutics, Clinical Development, Concord, United States TrialPhase 1 ConferenceECCO 2021 2 July, 2021 22:37
Surgical closure plus anti-TNF outperforms anti-TNF alone for perianal fistula Presented ByMs Elise Meima-van Praag , Amsterdam University Medical Centre, the Netherlands TrialPISA-II ConferenceECCO 2021 2 July, 2021 21:45
Blood proteins predicting relapse in CD identified Presented ByMr Nicolas Pierre, University of Liège, Belgium TrialCohort study, STORI ConferenceECCO 2021 2 July, 2021 23:48
Extracellular RNA has potential as a non-invasive biomarker in IBD Presented ByDr Bram Verstockt , University Hospital Leuven, Belgium ConferenceECCO 2021 2 July, 2021 22:51
No increased risk of (severe) COVID-19 among IBD patients Presented ByDr Vered Richter , Tel Aviv University, Israel ConferenceECCO 2021 2 July, 2021 23:52
Oral faecal microbiota transplant therapy efficacious in UC Presented ByDr Craig Haifer, University of Sydney, Australia TrialLOTUS ConferenceECCO 2021 2 July, 2021 22:54
Artificial intelligence outperforms human classifying of endoscopic images in UC Presented ByDr Bobby Lo , Hvidovre Hospital, Denmark ConferenceECCO 2021 2 July, 2021 21:56
Increased risk of rectal cancer after colectomy in IBD Presented ByDr Elena Akimenko, Gentofte Hospital, Denmark ConferenceECCO 2021 2 July, 2021 20:58
Risk of colorectal cancer is detected by low-pass whole genome sequencing Presented ByDr Ibrahim Al Bakir, Queen Mary University of London, UK ConferenceECCO 2021 2 July, 2021 19:03
Large variability in IBD care and education across Europe Presented ByDr Jan Král, Institute for Clinical and Experimental Medicine, Czech Republic ConferenceECCO 2021 2 July, 2021 18:07
Ultra-processed food intake associated with IBD Presented ByDr Neeraj Narula , McMaster University, UK ConferenceECCO 2021 2 July, 2021 17:09
Factors of coping difficulties in IBD revealed Presented ByMr J. Marshall, University of Sheffield, Academic Unit of Primary Medical Care, Sheffield, United Kingdom ConferenceECCO 2021 2 July, 2021 15:12
